# Pharmacists' Interventions to Improve Blood Pressure in Chronic Kidney Disease

Study · id `cardio:ct-nct05254392` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05254392](<https://clinicaltrials.gov/study/NCT05254392>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05254392

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 147 participants.

## Technical summary

Registry record NCT05254392. Randomized; double masking; primary purpose health services research. Start 2019-11-12 (actual); primary completion 2021-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 147 participants (enrolled count; ClinicalTrials.gov record NCT05254392, source copy `cardio:ctgov-nct05254392-2022-03-10`, retrieved 2026-10-26)
- Started: 2019-11-12 (actual) (ClinicalTrials.gov record NCT05254392, source copy `cardio:ctgov-nct05254392-2022-03-10`, retrieved 2026-10-26)
- Primary completion: 2021-01-31 (actual) (ClinicalTrials.gov record NCT05254392, source copy `cardio:ctgov-nct05254392-2022-03-10`, retrieved 2026-10-26)
- Completion: 2021-01-31 (actual) (ClinicalTrials.gov record NCT05254392, source copy `cardio:ctgov-nct05254392-2022-03-10`, retrieved 2026-10-26)
- Countries: Nigeria (ClinicalTrials.gov record NCT05254392, source copy `cardio:ctgov-nct05254392-2022-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05254392-2022-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pharmacists' Interventions to Improve Blood Pressure in Chronic Kidney Disease
- Condition: Chronic Kidney Diseases
- Intervention (Device): Digital BP monitor (Chidalex®)
- Lead sponsor: University of Maiduguri
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 39c23cdd2a5e0d0d532b47fec24b567c5d0c8007acc43141dbbe8c8b1fbb0642
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
